Teriparatide
FDA-approved bone anabolic PTH (parathyroid hormone, which manages calcium).
What it's for
FDA-approved bone anabolic PTH (parathyroid hormone, which manages calcium).
What it's for
Teriparatide is recombinant human PTH (parathyroid hormone, which manages calcium) amino acids 1–34. Treats osteoporosis at high risk of fracture in postmenopausal women, men with primary/hypogonadal osteoporosis, and glucocorticoid-induced osteoporosis as labeled.
What it does for the body
Treats osteoporosis at high risk of fracture in postmenopausal women, men with primary/hypogonadal osteoporosis, and glucocorticoid-induced osteoporosis as labeled. People often hear about it through clinics, forums, or news — this guide sticks to what published research and regulators actually support.
What it targets
Intermittent PTH1R activating its target pathway stimulates bone-building cell more than bone-resorbing cell, increasing bone formation. Researchers map these ideas in cells and animals first; human proof has to clear a higher bar.
Research context
Bottom line for readers: Teriparatide has a defined FDA-approved story. Use the citations tab to open labels and trial registries, and treat anything beyond the label as unverified.
Studied for (literature interest)
- Bones research interest (educational tag)
Cautions (educational)
- Educational only — not medical advice.
- DrPep does not offer medical consultations, dosing guidance, suppliers, or peptide sales.
Citations / starters
- FDA search: Teriparatide — FDA.gov search
- ClinicalTrials.gov search: Teriparatide — U.S. clinical trials registry
- Drugs@FDA search: Teriparatide — FDA drug database (if approved)
- PubMed search: Teriparatide — NCBI PubMed
- PubMed Central search: Teriparatide — NCBI PMC